Aspects of Regulation of Xenotransplantation in Europe
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.The Council of Europe and European Union enhance cooperation on Substances of Human Origin (SoHO) regulation, building on shared values. This collaboration aims to establish consistent legal standards across Europe, excluding xenotransplantation from current agreements.
Area Of Science
- Public Health Law
- European Governance
- Biotechnology Regulation
Background
- The Council of Europe (CoE) and European Union (EU) uphold shared values: human rights, democracy, and rule of law.
- CoE establishes minimum legal standards and monitors compliance, often collaborating with the EU.
- EU integrates European values into its political and economic processes, frequently referencing CoE standards.
Purpose Of The Study
- To outline the expanded cooperation between the CoE and EU in the field of Substances of Human Origin (SoHO).
- To highlight the recent EU regulation on SoHO and its relationship with existing CoE frameworks.
- To clarify the scope of the new agreement, specifically noting the exclusion of xenotransplantation.
Main Methods
- Analysis of the agreement between the CoE and EU on SoHO cooperation.
- Review of the EU's 2024 regulation on Substances of Human Origin.
- Examination of the European Committee on Organ Transplantation (CD-P-TO) role within the CoE.
Main Results
- An agreement has been concluded between the CoE and EU to enhance cooperation on SoHO.
- The EU's SoHO regulation, effective from 2024, builds upon existing CoE standards.
- Xenotransplantation is explicitly excluded from the scope of the discussed Substances of Human Origin regulation.
Conclusions
- The CoE and EU cooperation strengthens the regulatory framework for Substances of Human Origin in Europe.
- This collaboration ensures greater consistency in legal standards for human tissues and cells.
- Future regulatory developments may need to address areas such as xenotransplantation separately.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...